Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

According to recent disclosures, the transaction carries an approximately $835 million combined valuation: $660 million attributed to Z-Squared's technology infrastructure operations, $75 million to a ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...

The "Biological Therapies for Cancer: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Why does cancer sometimes recur after chemotherapy? Why do some bacteria survive antibiotic treatment? In many cases, the ...

Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...

OneOncology supports 33 practices, providing infrastructure and expertise for advanced therapies and value-based care, while ...

Cancer has long been treated as a mass of rogue cells, but the real power lies in the intricate communication networks ...

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%. Despite this poor prognosis, SCLC is initially highly responsive to ...

The development of glmSMA represents a valuable advancement in spatial transcriptomics analysis, offering a mathematically robust regression-based approach that achieves higher-resolution mapping of ...

Illustration of a T lymphocyte white blood cell, depicted in blue, attacking a cancer cell, shown in red Nemes Laszlo / Science Photo Library via Getty Images CAR T-cell therapy can be a lifesaving ...